Healthcare enforcement
PBM Transparency Moves From Reform Proposal to Pricing Design
Optum Rx’s fee-based PBM model adds market context to DOL’s proposed PBM fee-disclosure rule and the broader push for compensation transparency.
Healthcare enforcement
Optum Rx’s fee-based PBM model adds market context to DOL’s proposed PBM fee-disclosure rule and the broader push for compensation transparency.
AI Governance
New federal bank model-risk guidance excludes generative and agentic AI from scope, but points governance back to banks’ own risk controls.
AI Agent Governance
HBR research shows AI “employee” framing can blur accountability and reduce review quality. The governance fix is not better job titles for agents — it is clearer human ownership, decision rights, and evidence.
State AI Laws
Connecticut SB 5 is now law. Here’s how AI governance teams should map employment AI, AI companions, provenance, frontier-model controls, and preemption-sensitive obligations.
State AI Laws
Colorado’s SB26-189 may narrow one AI explanation requirement, but developers and deployers still face documentation, records, notice, and review obligations.
Cybersecurity Risk
CISA’s CI Fortify guidance urges critical infrastructure operators to plan for isolation, recovery, vendor dependencies, and essential service continuity during cyber disruption.
Tariff
CAPE Phase 1 opened the refund path. Now CFOs need to control how IEEPA tariff refunds move through tax, inventory, contracts, and customer expectations.
AI Governance
CSA data shows a gap between enterprise confidence and AI-agent control coverage. The issue is not just unknown agents — it is whether governance can prove each autonomous workflow is known, scoped, permissioned, monitored, and retired.
Federal Oversight
GAO’s FY2025 improper-payment estimate rose to about $186B, but the deeper issue is visibility: the total does not capture the full government-wide picture.
Supply chain risk
Middle East conflict is pushing cost pressure into PCB raw-material inputs, exposing a less visible supply-chain layer beneath AI servers and advanced electronics.
Healthcare Compliance Governance
FDA accelerated review pathways for selected psychedelic-based therapies, but the move does not approve the drugs, legalize access, or prove safety or effectiveness.
State AI Laws
State AI laws are shifting before enforcement patterns mature. Colorado, California, Utah, and New York show why AI governance teams need to track live obligations, delayed triggers, proposed amendments, and guidance gaps.